北美神经毒素市场预测至 2028 年 - COVID-19 影响和区域分析 - 按产品类型（Botox、Dysport、Xenomin 等）、应用（治疗和美容）和最终用户（医院、专科诊所、皮肤科诊所和其他的）
No. of Pages: 99 | Report Code: BMIRE00028824 | Category: Life Sciences
No. of Pages: 99 | Report Code: BMIRE00028824 | Category: Life Sciences
预计神经毒素的整体市场将在预测期内呈指数级增长，以满足日益增长的面部美容需求。 2022年3月，Aquavit Pharmaceuticals, Inc.宣布提交“DTX-021”的研究新药（IND）——一种A型肉毒毒素，旨在治疗中度至重度眉间纹。该产品是一种高度纯化且经过临床测试的可注射神经调节剂，含有源自肉毒梭菌产生的神经毒素的 900 kDa 蛋白质复合物。此外，Aquavit 正在通过推出 DTX-022 加速临床试验，其最终批准将被认为是首个、也是世界上第一个全面部微注射神经毒素的产品。同样，随着减肥趋势的持续，胃肉毒杆菌已成为寻求非侵入性手术的患者的热门选择。它涉及使用内窥镜技术将肉毒杆菌注射到特定的胃部区域。通过这种技术，可以抑制胃部肌肉的收缩。由于这种限制，胃的排空过程需要更长的时间，这导致患者长时间感到饱腹感，从而导致食欲下降并改善与体重相关的健康问题/生活方式障碍，例如高血压和糖尿病。因此，创新面部美容产品的出现有助于北美神经毒素市场的增长。
北美神经毒素市场分为美国、加拿大和墨西哥。美国是最大且增长最快的神经毒素市场。该地区的市场增长归因于产品推出的增加、FDA 对用于各种肌肉疾病的神经毒素的批准不断增加、人口老龄化、非手术或微创美容手术数量的增加、美容手术数量的增加以及对神经毒素的需求不断增长微创疗法。
北美神经毒素市场细分
北美神经毒素市场按产品类型、应用、最终用户和国家/地区进行细分。根据产品类型，北美神经毒素市场细分为肉毒杆菌、dysport、xenomin 等。肉毒杆菌细分市场在 2023 年占据最大的市场份额。
根据应用，北美神经毒素市场分为治疗和美容。到2023年，治疗领域将占据更大的市场份额。
根据最终用户，北美神经毒素市场分为医院、专科诊所、皮肤科诊所等。 2023 年，医院细分市场占据最大的市场份额。
根据国家/地区，北美神经毒素市场分为美国、加拿大和墨西哥。到 2023 年，美国将占据市场份额。
AbbVie Inc、Hugel Inc、Ipsen SA、Meditox Inc、Merz Pharma GmbH & Co KGaA、Metabiologics 和 Revance Therapeutics Inc 是北美神经毒素市场的领先公司之一。
Strategic insights for North America Neurotoxins involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 4,801.29 Million |
| Market Size by 2028 | US$ 8,416.95 Million |
| Global CAGR (2023 - 2028) | 11.9% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2028 |
| Segments Covered |
By 产品类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Neurotoxins refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Neurotoxins Market is valued at US$ 4,801.29 Million in 2023, it is projected to reach US$ 8,416.95 Million by 2028.
As per our report North America Neurotoxins Market, the market size is valued at US$ 4,801.29 Million in 2023, projecting it to reach US$ 8,416.95 Million by 2028. This translates to a CAGR of approximately 11.9% during the forecast period.
The North America Neurotoxins Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Neurotoxins Market report:
The North America Neurotoxins Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Neurotoxins Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Neurotoxins Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Neurotoxins Market
